GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InventisBio Co Ltd (SHSE:688382) » Definitions » Gross-Profit-to-Asset %

InventisBio Co (SHSE:688382) Gross-Profit-to-Asset % : 0.74% (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is InventisBio Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. InventisBio Co's annualized Gross Profit for the quarter that ended in Sep. 2024 was ¥14.28 Mil. InventisBio Co's average Total Assets over the quarter that ended in Sep. 2024 was ¥1,932.62 Mil. Therefore, InventisBio Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 was 0.74%.


InventisBio Co Gross-Profit-to-Asset % Historical Data

The historical data trend for InventisBio Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InventisBio Co Gross-Profit-to-Asset % Chart

InventisBio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 159.84 - - - 8.23

InventisBio Co Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.65 10.81 0.86 0.79 0.74

Competitive Comparison of InventisBio Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, InventisBio Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InventisBio Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InventisBio Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where InventisBio Co's Gross-Profit-to-Asset % falls into.



InventisBio Co Gross-Profit-to-Asset % Calculation

InventisBio Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=185.527/( (2347.827+2162.272)/ 2 )
=185.527/2255.0495
=8.23 %

InventisBio Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=14.276/( (1973.823+1891.407)/ 2 )
=14.276/1932.615
=0.74 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


InventisBio Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of InventisBio Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


InventisBio Co Business Description

Traded in Other Exchanges
N/A
Address
No. 4, Lane 67, Li Bing Road, Room 210, Pilot Free Trade Zone, Shanghai, CHN, 201203
InventisBio Co Ltd is an innovative drug research and development enterprise based in China with a global perspective, focusing on major diseases such as tumors and metabolic diseases. It has independently developed a series of innovative targeted drugs with patent protection, covering non-small cell lung cancer, breast cancer, colorectal cancer and other solid tumors, as well as hyperuricemia and metabolic diseases such as gout.

InventisBio Co Headlines

No Headlines